Advertisement

Topics

Antibe Therapeutics Inc. Announces Closing of Public Offering

08:45 EDT 21 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSXV: ATE) (OTCQX: ATBPF) a diversified biotechnology company announced today the first closing of its previously announced marketed public offering of units (the “...

Other Sources for this Article

Antibe Therapeutics Inc.
Dan Legault, +1 416-473-4095
Chief Executive Officer
dan.legault@antibethera.com

NEXT ARTICLE

More From BioPortfolio on "Antibe Therapeutics Inc. Announces Closing of Public Offering"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...